Literature DB >> 17942673

Distinctive patterns of microRNA expression in primary muscular disorders.

Iris Eisenberg1, Alal Eran, Ichizo Nishino, Maurizio Moggio, Costanza Lamperti, Anthony A Amato, Hart G Lidov, Peter B Kang, Kathryn N North, Stella Mitrani-Rosenbaum, Kevin M Flanigan, Lori A Neely, Duncan Whitney, Alan H Beggs, Isaac S Kohane, Louis M Kunkel.   

Abstract

The primary muscle disorders are a diverse group of diseases caused by various defective structural proteins, abnormal signaling molecules, enzymes and proteins involved in posttranslational modifications, and other mechanisms. Although there is increasing clarification of the primary aberrant cellular processes responsible for these conditions, the decisive factors involved in the secondary pathogenic cascades are still mainly obscure. Given the emerging roles of microRNAs (miRNAs) in modulation of cellular phenotypes, we searched for miRNAs regulated during the degenerative process of muscle to gain insight into the specific regulation of genes that are disrupted in pathological muscle conditions. We describe 185 miRNAs that are up- or down-regulated in 10 major muscular disorders in humans [Duchenne muscular dystrophy (DMD), Becker muscular dystrophy, facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophies types 2A and 2B, Miyoshi myopathy, nemaline myopathy, polymyositis, dermatomyositis, and inclusion body myositis]. Although five miRNAs were found to be consistently regulated in almost all samples analyzed, pointing to possible involvement of a common regulatory mechanism, others were dysregulated only in one disease and not at all in the other disorders. Functional correlation between the predicted targets of these miRNAs and mRNA expression demonstrated tight posttranscriptional regulation at the mRNA level in DMD and Miyoshi myopathy. Together with direct mRNA-miRNA predicted interactions demonstrated in DMD, some of which are involved in known secondary response functions and others that are involved in muscle regeneration, these findings suggest an important role of miRNAs in specific physiological pathways underlying the disease pathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942673      PMCID: PMC2040449          DOI: 10.1073/pnas.0708115104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  A single-molecule method for the quantitation of microRNA gene expression.

Authors:  Lori A Neely; Sonal Patel; Joanne Garver; Michael Gallo; Maria Hackett; Stephen McLaughlin; Mark Nadel; John Harris; Steve Gullans; Jenny Rooke
Journal:  Nat Methods       Date:  2006-01       Impact factor: 28.547

2.  MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling.

Authors:  Chulan Kwon; Zhe Han; Eric N Olson; Deepak Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

Review 3.  Signaling pathways in skeletal muscle remodeling.

Authors:  Rhonda Bassel-Duby; Eric N Olson
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

Review 4.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

Review 5.  Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Nat Clin Pract Rheumatol       Date:  2006-04

6.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

Review 7.  Facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil; Silvère M Van Der Maarel
Journal:  Muscle Nerve       Date:  2006-07       Impact factor: 3.217

Review 8.  Molecular mechanisms of muscular dystrophies: old and new players.

Authors:  Kay E Davies; Kristen J Nowak
Journal:  Nat Rev Mol Cell Biol       Date:  2006-09-13       Impact factor: 94.444

9.  Muscle-specific microRNA miR-206 promotes muscle differentiation.

Authors:  Hak Kyun Kim; Yong Sun Lee; Umasundari Sivaprasad; Ankit Malhotra; Anindya Dutta
Journal:  J Cell Biol       Date:  2006-08-21       Impact factor: 10.539

10.  MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206.

Authors:  Miriam I Rosenberg; Sara A Georges; Amy Asawachaicharn; Erwin Analau; Stephen J Tapscott
Journal:  J Cell Biol       Date:  2006-10-09       Impact factor: 10.539

View more
  247 in total

1.  Systems analysis reveals down-regulation of a network of pro-survival miRNAs drives the apoptotic response in dilated cardiomyopathy.

Authors:  Ruth Isserlin; Daniele Merico; Dingyan Wang; Dajana Vuckovic; Nicolas Bousette; Anthony O Gramolini; Gary D Bader; Andrew Emili
Journal:  Mol Biosyst       Date:  2014-10-31

2.  Determination of miRNA targets in skeletal muscle cells.

Authors:  Zhan-Peng Huang; Ramón Espinoza-Lewis; Da-Zhi Wang
Journal:  Methods Mol Biol       Date:  2012

3.  Application of microRNA in cardiac and skeletal muscle disease gene therapy.

Authors:  Zhan-Peng Huang; Ronald L Neppl; Da-Zhi Wang
Journal:  Methods Mol Biol       Date:  2011

4.  Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.

Authors:  Yasunari Matsuzaka; Soichiro Kishi; Yoshitsugu Aoki; Hirofumi Komaki; Yasushi Oya; Shin-Ichi Takeda; Kazuo Hashido
Journal:  Environ Health Prev Med       Date:  2014-08-24       Impact factor: 3.674

5.  Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy.

Authors:  Junaith S Mohamed; Ameena Hajira; Michael A Lopez; Aladin M Boriek
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

6.  The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy.

Authors:  Xin Chen; Yun-Qian Gao; Yan-Yan Zheng; Wei Wang; Pei Wang; Juan Liang; Wei Zhao; Tao Tao; Jie Sun; Lisha Wei; Yeqiong Li; Yuwei Zhou; Zhenji Gan; Xuena Zhang; Hua-Qun Chen; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 7.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

Review 8.  Recent advances in myotonic dystrophy type 2.

Authors:  Christina M Ulane; Sarah Teed; Jacinda Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 9.  Fragile hearts: new insights into translational control in cardiac muscle.

Authors:  Daniela C Zarnescu; Carol C Gregorio
Journal:  Trends Cardiovasc Med       Date:  2013-04-10       Impact factor: 6.677

10.  PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes.

Authors:  Andreas Ruepp; Andreas Kowarsch; Daniel Schmidl; Felix Buggenthin; Barbara Brauner; Irmtraud Dunger; Gisela Fobo; Goar Frishman; Corinna Montrone; Fabian J Theis
Journal:  Genome Biol       Date:  2010-01-20       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.